Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Tumor-like multiple sclerosis.
Substance Name: Dronabinol
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
Mesenchymal stem cells as treatment for MS - progress to date.
Anti-integrin therapy for multiple sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Mobile phones and multiple sclerosis - a nationwide cohort study in denmark.
The benefits of exercise training in multiple sclerosis.
Pediatric multiple sclerosis in Venezuela.
Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.
Structure and Activity of the Acid Sensing Ion Channels.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Gray matter is targeted in first-attack multiple sclerosis.
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »